Ryo Sato

6PUBLICATIONS
12CO-AUTHORS
Nephrology and urologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2025
Efficacy and safety of lithotripsy with ureteroscopy for ureteral stones in octogenarians.

Ryo Sato, Asuka Uchiyama, Shungo Kakinuma

|Jun 22, 2023
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan.

Ken-Ichi Harada, Ryo Sato, Yukari Bando

|Dec 28, 2022
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.

Ryo Sato, Teruo Inamoto, Yuto Matsushita

|Dec 13, 2022
Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.

Kyohei Watanabe, Atsushi Otsuka, Asuka Sano

|Apr 24, 2022
Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.

Yuto Matsushita, Asuka Kawakami, Ryo Sato

|Jul 30, 2021
Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.

Ryo Sato, Kyohei Watanabe, Yuto Matsushita

Pageof 1

Frequent Collaborators

5 joint publications

Yuto Matsushita

3 joint publications

Kyohei Watanabe

2 joint publications

Keita Tamura

2 joint publications

Atsushi Otsuka